Signal Transducer and Activator of Transcription 1 Is Required for Optimal Foam Cell Formation and Atherosclerotic Lesion Development
暂无分享,去创建一个
[1] R. Silverstein,et al. Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o /apoEo mice . , 2007, Atherosclerosis.
[2] C. Funk. Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[3] E. Tuzcu,et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). , 2006, The American journal of cardiology.
[4] Jonathan D. Smith,et al. Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis Published, JLR Papers in Press, October 7, 2005. , 2006, Journal of Lipid Research.
[5] K. Moore,et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.
[6] S. Mariotto,et al. STAT1 as a new molecular target of anti-inflammatory treatment. , 2005, Current medicinal chemistry.
[7] B. Gao,et al. Cytokines, STATs and liver disease. , 2005, Cellular & molecular immunology.
[8] R. Silverstein,et al. Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[9] Roger A. Davis,et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .
[10] G. Sumara,et al. Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis , 2004, Science.
[11] P. Shah,et al. Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null Mice , 2004, Circulation.
[12] Deborah A. Corey,et al. Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[13] Anastasis Stephanou,et al. STAT‐1: a novel regulator of apoptosis , 2003, International journal of experimental pathology.
[14] Scott D Covey,et al. Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[15] G. Feldman,et al. Interleukin-13 Induction of 15-Lipoxygenase Gene Expression Requires p38 Mitogen-Activated Protein Kinase-Mediated Serine 727 Phosphorylation of Stat1 and Stat3 , 2003, Molecular and Cellular Biology.
[16] S. Yamashita,et al. Pathophysiology of human genetic CD36 deficiency. , 2003, Trends in cardiovascular medicine.
[17] N. Sepp,et al. Adhesion of dendritic cells derived from CD34+ progenitors to resting human dermal microvascular endothelial cells is down‐regulated upon maturation and partially depends on CD11a–CD18, CD11b–CD18 and CD36 , 2002, European journal of immunology.
[18] Ruediger C. Braun-Dullaeus,et al. Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.
[19] A. Daugherty,et al. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[20] T. Decker,et al. IFNs and STATs in innate immunity to microorganisms. , 2002, The Journal of clinical investigation.
[21] Massimo Gadina,et al. Cytokine Signaling in 2002 New Surprises in the Jak/Stat Pathway , 2002, Cell.
[22] Chilakamarti V. Ramana,et al. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .
[23] M. Linton,et al. Class A scavenger receptors, macrophages, and atherosclerosis , 2001, Current opinion in lipidology.
[24] R. Silverstein,et al. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.
[25] L. Bernier,et al. Identification of a &ggr;-Interferon-Responsive Element in the Promoter of the Human Macrophage Scavenger Receptor A Gene , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[26] Christopher K. Glass,et al. Atherosclerosis The Road Ahead , 2001, Cell.
[27] T. Kodama,et al. Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[28] A. Daugherty,et al. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .
[29] J. George,et al. Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor–Deficient Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[30] G. Stark,et al. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.
[31] D. Steinberg,et al. The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.
[32] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.
[33] S. Hazen,et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.
[34] E. Coccia,et al. STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules. , 1999, International immunology.
[35] S. Hazen,et al. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.
[36] H. Huynh,et al. Involvement of insulin-like growth factor-1 and its binding proteins in proliferation and differentiation of murine bone marrow-derived macrophage precursors , 1998, Endocrine.
[37] A. Tall,et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.
[38] P. Howe,et al. Oxidized Low Density Lipoprotein and Lysophosphatidylcholine Stimulate Cell Cycle Entry in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.
[39] S. Yoshida,et al. Effects of Interferon-α, β, and γ on the Function of Differentiated Leukemic HL-60 Cells Induced by 1,25-Dihydroxyvitamin D3 , 1996 .
[40] B. Lehnert,et al. Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. , 1995, Journal of immunological methods.
[41] G. Hoppe,et al. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. , 1994, The Journal of clinical investigation.
[42] P. Grimaldi,et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. , 1993, The Journal of biological chemistry.
[43] J. Darnell,et al. Induction of the Ly-6A/E gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Akagawa,et al. Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages. , 1988, Journal of immunology.
[45] Roger A. Davis,et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. , 2004, The Journal of clinical investigation.
[46] G. Stark,et al. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. , 2002, Trends in immunology.
[47] A. Daugherty,et al. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. , 2000, The American journal of pathology.
[48] S. Zuckerman,et al. Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma. , 2000, Journal of lipid research.
[49] S. Hazen,et al. Erratum: Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (Journal of Clinical Investigation (2000) 105 (1095-1108)) , 2000 .
[50] S. Yoshida,et al. Effects of interferon-alpha, beta, and gamma on the function of differentiated leukemic HL-60 cells induced by 1,25-dihydroxyvitamin D3. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.